GOT2P7

Across TCGA pan-cancer cohorts, GOT2P7 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated GOT2P7 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher GOT2P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GOT2P7 expression acts as an unfavorable survival marker, although some lineages such as STAD and HNSC show a favorable association.

ACC, LAML, and SKCM are the cancer types where GOT2P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	IV	0.010	0.383	<.001	45	view →
LAML	DFS	Quartile	All	0.268	0.585	.008	26	view →
SKCM	OS	Tertile	II,III,IV	0.113	0.321	.026	18	view →
TGCT	DFS	Tertile	All	0.673	0.840	.029	18	view →
THCA	OS	Tertile	II,III,IV	0.630	0.863	.013	18	view →
UCEC	OS	Tertile	All	0.871	0.931	.021	18	view →
PCPG	OS	Tertile	All	0.828	0.963	<.001	15	view →
UCS	OS	Tertile	All	0.316	0.597	.023	12	view →
STAD	OS	Median	IV	0.511	0.176	.005	9	view →
KICH	DFS	Tertile	IV	0.317	0.923	.038	9	view →
MESO	OS	Tertile	II,III,IV	0.373	0.581	.048	9	view →
LIHC	OS	Tertile	II,III,IV	0.134	0.626	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

GOT2P7–ACC (DFS)

Open the ACC breakdown →